Introduction
Fluctuations in the body throughout the years surrounding menopause can increase the susceptibility to specific health issues. Diminished estrogen levels and other age-related alterations, such as weight gain, can heighten the likelihood of developing heart disease, stroke, and osteoporosis.
What Is the Process of Assessing the Menopausal Transition?
Menopause occurs 12 months following the end of a woman's last menstrual cycle. The menopausal transition or perimenopause refers to the years before that period, during which women may experience changes in their menstrual cycles, hot flashes, or other symptoms.
The menopausal transition typically commences between the ages of 45 and 55 years. It typically lasts for seven years, but it may extend to fourteen years. The duration of the condition may be dependent upon lifestyle factors, including age at onset, race, and ethnicity. The body's release of estrogen and progesterone, two hormones produced by the ovaries, differs significantly during perimenopause.
Each woman experiences the menopausal transition in a way that is distinct and diverse. The body begins to utilize energy in a different manner, adipose cells undergo a transformation, and women may experience an increased likelihood of weight gain. The physical function, body shape and composition, or bone or cardiac health may be affected.
What Are the Various Alterations That Happen to the Body During Menopause?
Several physiological changes may occur during perimenopause and menopause that can impact one's health.
Osteoporosis
Estrogen has a function in preventing bone breakdown. During bone resorption, osteoclasts degrade the tissues within the bones. During menopause, a decrease in estrogen production by the body causes bone loss to exceed the rate of new bone formation.
Engaging in weight-bearing and balancing activities can be beneficial in addition to maintaining proper posture.
Patients have a significant risk of bone fractures, and the healthcare professional may prescribe certain drugs. Certain medications, such as hormone therapy, can inhibit additional bone loss or reduce the likelihood of fractures.
Changes in Mental Capacities
Brain fog is a common symptom that some individuals experience during perimenopause. Mental activity impairment may manifest as memory lapses and having trouble remembering words, commonly referred to as brain fog. However, the correlation between cognitive changes and hormone alterations is unresolved.
Early onset of menopause, occurring in individuals aged 40 or younger, has long-lasting adverse effects on mental performance.
Cardiovascular Disease
The decrease in estrogen levels can potentially elevate the susceptibility to heart disease. Estrogen often aids in maintaining the flexibility of blood arteries, hence enhancing circulation.
Menopause is not a direct cause of heart disease. As the individual becomes older, additional risk factors may arise.
-
Elevated levels of LDL are sometimes referred to as "bad" cholesterol.
-
Hypertension.
-
Reduced levels of high-density lipoprotein (HDL), sometimes referred to as "good" cholesterol.
-
A diet rich in high levels of fat.
-
Tobacco consumption.
-
Insufficient physical activity.
-
Adopting a nutritious diet, engaging in regular physical activity, and abstaining from smoking can effectively reduce the likelihood of developing heart disease.
Fluctuations in Emotional State
Experiencing fluctuations in mood, ranging from happiness to sadness to anger and then returning to a previous state, are normal occurrences during perimenopause. Fluctuating hormone levels are a probable cause of mood fluctuations.
A history of depression may have an elevated chance of experiencing mood abnormalities after menopause. Insufficient sleep, frequently caused by nocturnal perspiration, can also affect the emotional state.
Engaging in stress-reducing activities, such as exercise, can effectively enhance the mood. Hormone therapy can also assist in regulating mood fluctuations.
Insomnia Sleep Disturbances
Sleep disturbances arise due to the occurrence of hot flashes and night sweats triggered by the decrease in estrogen levels. A decrease in progesterone, which is another hormone related to sex, can lead to disruptions in sleep. It is also not unusual for individuals to frequently wake up during the night to urinate.
Urinary Issues
Aside from vulvar degeneration and vaginal dryness, certain individuals may experience alterations in bladder function after menopause. Genitourinary syndrome of menopause (GSM) refers to the many bladder and genital alterations and symptoms that occur throughout menopause.
Bladder issues frequently occur due to stress relevance, characterized by the involuntary release of urine during coughing or sneezing. Individuals who have undergone several vaginal childbirths may have a higher likelihood of experiencing stress incontinence. Engaging in resistance training and undergoing hormone therapy can be beneficial.
What Are the Potential Consequences Linked to Menopause?
Potential consequences linked to menopause include adverse impacts on cardiovascular health, bone density, and mental abilities, which can be attributed to the absence of estrogen. During menopause, there is a decline in the body's hormone synthesis, which might elevate the susceptibility to many chronic illnesses, including:
-
Osteoporosis is a pathological condition defined by the existence of fragile bones that are susceptible to fractures. Menopause promotes bone resorption, hence increasing the risk of developing osteoporosis. The rate of decreased bone density varies among menopausal persons. Menopause does not necessarily entail the occurrence of osteoporosis.
-
A potential association exists between menopause and Alzheimer's disease. There is evidence suggesting that the decline in estrogen levels following menopause may increase the probability of acquiring the illness.
-
Evidence suggests that individuals are more prone to have psychiatric disorders such as feelings of melancholy and anxiety during the perimenopause and menopausal stages.
-
Venous thromboembolism (VTE) refers to the formation of blood clots in the veins, which can potentially travel to other parts of the body and cause blockages. There is data suggesting that the utilization of a combination of estrogen and progesterone hormone therapy is linked to a higher risk of venous thromboembolism (VTE) in comparison to using estrogen-only hormone therapy. Local treatments like Vagifem have a lower likelihood of causing venous thromboembolism (VTE) as compared to oral medications.
Healthcare practitioners may sometimes suggest hormone therapy as a method of replenishing diminished estrogen levels. Nevertheless, studies have revealed that hormone therapy may increase the probability of the following:
-
Estrogen reduces the probability of having a stroke. Estrogen has an impact on the operation of neurological and circulatory systems, as well as the pathways associated with inflammation. It influences the likelihood of experiencing a stroke. Although rare, there is evidence suggesting that hormone medication may increase the likelihood of experiencing a stroke.
-
The early use of hormone therapy does not elevate the likelihood of experiencing a stroke. Individuals who use hormone therapy that includes progestin during or near the period of menopause have an increased vulnerability to breast cancer. Progestin is a synthetic compound derived from progesterone.
Conclusion
Menopause can induce symptoms that impact the health of the bones, cardiovascular system, and mental well-being. As estrogen production decreases in the body, the likelihood of developing osteoporosis, cognitive decline, heart disease, and depression rises. Hormone therapy is a prevalent medical intervention used to improve symptoms associated with menopause and reduce the likelihood of developing related health issues. The hormone therapy might potentially lead to further risks such as stroke, venous thromboembolism (VTE), and breast cancer. It is important to get guidance from a medical professional regarding the most suitable course of treatment for the condition.
